Oklo Inc. (NYSE: OKLO) saw its stock climb 3% to $59.86 on Monday following the announcement that it has acquired ARMEC, a precision engineering and manufacturing firm based in Oak Ridge, Tennessee. The deal, which closed on June 4, is aimed at strengthening the company's internal capabilities for advanced reactor and fuel manufacturing, addressing a key criticism from investors who have questioned the company's valuation given its lack of commercial revenue.
Strategic Acquisition
The acquisition of ARMEC adds approximately 40 engineers and skilled workers to Oklo's team, along with more than two decades of experience in nuclear and industrial manufacturing. Oklo noted that ARMEC was free cash flow positive in its last fiscal year, though the purchase price was not disclosed. CEO Jacob DeWitte emphasized that "advanced nuclear deployment requires manufacturing depth," while ARMEC President Travis Reagan stated the deal positions his team to help build "the manufacturing foundation needed to support advanced nuclear deployment."
Market Context and Valuation
The move comes as investors weigh Oklo's $10.2 billion market capitalization against the fact that the company reported zero revenue for the first quarter, a net loss of $33.1 million, and operating expenses of $51.2 million. Cash, cash equivalents, and marketable debt securities totaled approximately $2.54 billion at the end of March. Analysts have noted that the company's strong balance sheet removes near-term funding risk, but the path to power sales remains dependent on regulatory approvals and fuel supply.
Oklo is working on the Aurora powerhouse, a fast reactor that uses liquid metal cooling and metal fuel, with a maximum output of 75 megawatts electric. The Nuclear Regulatory Commission (NRC) is currently in pre-application talks with Oklo regarding the design.
Key Catalyst: July Test Reactor
July is shaping up to be a pivotal month for Oklo. Atomic Alchemy, a company tied to Oklo, is targeting criticality—sustained nuclear reaction—at its Groves Isotopes Test Reactor in Texas. The U.S. Department of Energy's Reactor Pilot Program aims to have at least three advanced reactor concepts, not located at national labs, achieve criticality by July 4, 2026. While a successful test reactor milestone would be a positive sentiment driver, it would not immediately generate commercial power revenue.
Challenges Ahead
Despite the acquisition, Oklo faces significant hurdles. The company has cautioned that there is insufficient high-assay low-enriched uranium (HALEU) or plutonium-based fuel available on the market, and customers can back out of non-binding deals. Slow regulatory approvals could further delay construction and operations. The company's first-power goal remains set for late 2027 to early 2028.
Competitive Landscape
Southern Company (NYSE: SO), a regulated utility, represents the opposite end of the trade. Southern posted first-quarter adjusted earnings of $1.32 per share, up from $1.23 last year, with operating revenue of $8.4 billion, up 8% year-over-year. Southern's stock slipped about 1% to $91.67 on Monday, giving it a market cap near $103.4 billion. Meanwhile, NuScale Power (NYSE: SMR), a competitor in the small modular reactor space, gained 3.4% to $10.86.
Analyst Perspectives
HC Wainwright analyst Sameer Joshi noted that Oklo is still in the development stage, with the key near-term event being criticality at Atomic Alchemy's Groves reactor by July 4. Needham's Sean Milligan highlighted that Oklo's balance sheet eliminates near-term funding risk, as reported by Benzinga.
Conclusion
With the ARMEC acquisition, Oklo now has a tangible operating asset to show investors, moving beyond just a reactor design and a theory about demand. However, the market's next test will be whether the company can leverage July's milestones, regulatory progress, and a tighter supply chain to make power sales a realistic prospect.
